Business Wire - October 3, 2006
Dr. Bray previously led an industry-driven international program of several hundred international studies of HIV/AIDS therapy, including over a hundred conducted in developing countries. She has been involved in multiple international research programs including the DART trial, the largest HIV therapy trial ever conducted in Africa, the CIPRA projects funded by the U.S. National Institutes of Health, as well as advising on multiple clinical development programs in the biotech industry.
Dr. Bray received her Ph.D. from the School of Pharmacy at the University of London in 1988, and her Master of Science in Biology at the Jagiellonian University of Cracow, Poland, in 1979. Her awards and scholarships include The Winston Churchill Traveling Fellowship to study medicinal plants in Africa, The Sir Halley Stewart Trust Fellowship to study natural medicinal products, and The Royal Society Scholarship to study immunology in Paris. She serves as a reviewer for a number of scientific journals.
CytoDyn is developing Cytolin(R), targeted immune therapy for HIV/AIDS that is designed to restore immune function and that has produced encouraging data in pilot clinical trials. "We believe Dr. Bray's experience and expertise will be valuable across our entire pipeline," said CytoDyn's CEO Allen D. Allen. The Company's pipeline includes a polyvalent family of DNA-based pre-vaccines for influenza, and a product, Formaxycin(TM), that is intended to treat pre-cancerous conditions of the skin based upon a natural product long used by traditional healers in Africa.
Disclaimer
The information about Dr. Bray contained in this release was provided by Dr. Bray and is relied on by the Company in good faith. Although Dr. Bray's credentials in the field of HIV/AIDS are well known among experts in that field, the Company has made no independent effort to confirm this information. There can be no assurance that the efforts of Dr. Bray on behalf of the Company, if any, will produce positive results for the Company or increase its value.
CONTACT: CytoDyn, Inc.
Corinne Allen or Stacia Roum, 505-988-5520
SOURCE: CytoDyn, Inc.
061003
BW061002
Copyright © 2006 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .